Amesite net loss widens to $678,000 in Q3 FY26; revenue more than doubles to $83,332

Amesite Inc.

Amesite Inc.

AMST

0.00

  • Amesite posted a net loss of $678,000 for the quarter ended March 31, 2026, versus a net loss of $663,000 a year earlier.
  • Revenue rose 171.53% to $83,332 from the prior-year quarter.
  • Cash, cash equivalents and restricted cash totaled $740,711 as of March 31, 2026.
  • The company said it has pivoted toward healthcare solutions, with its NurseMagic app gaining traction with larger entities.
  • Nasdaq granted an extension to regain compliance through April 27, 2026; following an April 28 financing that raised about $2.2 million in net proceeds, Nasdaq notified the company on May 4 that it was back in compliance with the $2.5 million stockholders’ equity requirement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amesite Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-058512), on May 18, 2026, and is solely responsible for the information contained therein.